OCA

Octagon Capital Advisors Portfolio holdings

AUM $456M
This Quarter Return
+25.07%
1 Year Return
+48.55%
3 Year Return
+560.4%
5 Year Return
10 Year Return
AUM
$642M
AUM Growth
+$642M
Cap. Flow
+$89.9M
Cap. Flow %
13.99%
Top 10 Hldgs %
78.63%
Holding
44
New
9
Increased
4
Reduced
7
Closed
12
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APLS icon
1
Apellis Pharmaceuticals
APLS
$3.48B
$163M 25.44% 3,160,000 +656,941 +26% +$34M
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$66.9M 10.41% 2,551,703
VRNA
3
Verona Pharma
VRNA
$9.16B
$64.5M 10.04% 2,468,000 +1,143,132 +86% +$29.9M
RCUS icon
4
Arcus Biosciences
RCUS
$1.13B
$51.3M 7.99% 2,482,700 -185,616 -7% -$3.84M
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$34M 5.29% 750,000 +529,000 +239% +$24M
CLDX icon
6
Celldex Therapeutics
CLDX
$1.47B
$33.9M 5.28% 761,398
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$27.4M 4.26% +1,278,000 New +$27.4M
VRDN icon
8
Viridian Therapeutics
VRDN
$1.5B
$24.1M 3.75% +824,200 New +$24.1M
TNDM icon
9
Tandem Diabetes Care
TNDM
$845M
$21.3M 3.32% 474,929
JBIO
10
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$18.2M 2.84% +621,712 New +$18.2M
XBI icon
11
SPDR S&P Biotech ETF
XBI
$5.07B
$16.6M 2.58% 199,417 -43,983 -18% -$3.65M
VERA icon
12
Vera Therapeutics
VERA
$1.38B
$12.9M 2% 665,156 +131,892 +25% +$2.55M
ITCI
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11.7M 1.82% 220,953
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$11.7M 1.82% +1,859,200 New +$11.7M
FDMT icon
15
4D Molecular Therapeutics
FDMT
$288M
$11.1M 1.73% 499,996
ALPN
16
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$9M 1.4% 1,225,000
ITOS icon
17
iTeos Therapeutics
ITOS
$8.69M 1.35% +445,000 New +$8.69M
VKTX icon
18
Viking Therapeutics
VKTX
$3.04B
$8.18M 1.27% +870,500 New +$8.18M
RNA icon
19
Avidity Biosciences
RNA
$5.99B
$7.2M 1.12% 324,629 -55,000 -14% -$1.22M
BBIO icon
20
BridgeBio Pharma
BBIO
$9.89B
$7.12M 1.11% 933,743
STOK icon
21
Stoke Therapeutics
STOK
$1.08B
$7.05M 1.1% 763,456
XLO icon
22
Xilio Therapeutics
XLO
$36.3M
$6.52M 1.02% 2,425,000
ETNB icon
23
89bio
ETNB
$1.34B
$4.84M 0.75% +380,000 New +$4.84M
GOSS icon
24
Gossamer Bio
GOSS
$562M
$4.25M 0.66% 1,958,069 -87,373 -4% -$190K
MIRM icon
25
Mirum Pharmaceuticals
MIRM
$3.71B
$1.95M 0.3% 100,000